Skip to content
Catalyst

PapersPMID:33865017

Fucoxanthin rescues dexamethasone induced C2C12 myotubes atrophy.

Biomedicine & pharmacotherapy2021The record ↗

  1. Finding, insufficient evidenceraisesSIRT1

What moved

1 findingHow to read these marks →
  • Activates SIRT1

    insufficient

    “Through activating SIRT1, fucoxanthin inhibits forkhead box O (FoxO) transcriptional activity to reduce protein degradation, induces autophagy to enhance degraded protein clearance, promotes mitochondrial function and diminishes apoptosis.”
    Study
    in vitro · not in humans
    Dose studied
    fucoxanthin 10 μM
    Population
    C2C12 myotubes with dexamethasone-induced atrophy

Study record

Design
in vitro
Species
cells
Population
C2C12 myotubes with dexamethasone (10 μM)-induced atrophy
Participants
not reported
Comparator
not stated in the paper / placebo
Duration
not reported
Endpoints measured
3